5c study

Clinical and Cost-Effectiveness of a Comprehensive Geriatric Assessment in Canada Elders Receiving Chemotherapy

CLINICALTRIALS.GOV 

Registration Number: NCT03154671

The Primary Objective of the 5C study is to determine the clinical effectiveness of the intervention on maintaining/improving quality of life in older adults aged > 70 years referred for adjuvant/curative or first/second line palliative chemotherapy compared to usual oncology care.

A cost-effectiveness analysis will also be done alongside the clinical trial. 

THE STUDY WILL BE CONDUCTED AT THE FOLLOWING:

University Health Network, Toronto 

The Ottawa Hospital, Ottawa

Sir Mortimer B. Davis - Jewish General Hospital, Montreal

R.S. McLaughlin Durham Cancer Centre, Lakeridge Health, Oshawa

Sunnybrook Health Sciences Centre, Toronto

Fraser Health- Royal Columbian Hospital, Surrey 

Mount Sinai Hospital, Toronto

For more information, please contact the study PI: 

Dr. Martine Puts

(416) 978-6059

martine.puts@utoronto.ca

Funding provided by: Canadian Cancer Society 

  • White Facebook Icon
  • White Twitter Icon
  • White Pinterest Icon
  • White Instagram Icon